SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-20-005525
Filing Date
2020-03-05
Accepted
2020-03-05 17:07:10
Documents
3
Group Members
ABIR RAVEH

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D ea119347-13da1rimon_wize.htm SC 13D/A 69019
2 SECOND AMENDMENT TO CONVERTIBLE LOAN AGREEMENT DATED NOVEMBER 29, 2019 ea119347ex8rimon_wize.htm EX-8 49963
3 FORM OF SECOND 2019 WARRANT ea119347ex9rimon_wize.htm EX-9 117428
  Complete submission text file 0001213900-20-005525.txt   238062
Mailing Address 24 HANAGAR ST HOD HASHARON L3 4527713
Business Address 24 HANAGAR ST HOD HASHARON L3 4527713 972 472 260 0536
Wize Pharma, Inc. (Subject) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82946 | Film No.: 20691611
SIC: 2834 Pharmaceutical Preparations

Mailing Address RAVEN RAVID & CO. 32A HABARZEL ST. TEL AVIV L3 6971047
Business Address RAVEN RAVID & CO. 32A HABARZEL ST. TEL AVIV L3 6971047 972-3-7676999
Rimon Gold Assets Ltd (Filed by) CIK: 0001721808 (see all company filings)

IRS No.: 514819424
Type: SC 13D/A